Naz Rahman
Stock Analyst at Maxim Group
(0.09)
# 4,502
Out of 4,556 analysts
456
Total ratings
38.5%
Success rate
-7.4%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Reiterated: Buy | $30 | $14.60 | +105.48% | 14 | Jul 15, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $16 | $4.38 | +265.71% | 34 | Jul 10, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $575 | $472.57 | +21.68% | 34 | Jul 9, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $1.5 | $0.40 | +275.00% | 3 | Jul 9, 2026 | |
| VANI Vivani Medical | Reiterated: Buy | $4 | $1.39 | +187.77% | 26 | Jul 8, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.90 | +321.05% | 31 | Jun 29, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $70 | $37.31 | +87.62% | 37 | Jun 25, 2026 | |
| SLXN Silexion Therapeutics | Reiterated: Buy | $60 → $6 | $2.52 | +138.10% | 23 | Jun 24, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $17 → $30 | $19.29 | +55.52% | 13 | Jun 23, 2026 | |
| GLMD Galmed Pharmaceuticals | Maintained: Hold | n/a | $0.5049 | - | 13 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $7.90 | +51.90% | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.84 | +65.29% | 27 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €3.79 | +321.94% | 6 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.411 | +386.62% | 33 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.29 | +132.56% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $2.16 | +224.07% | 20 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.82 | +243.64% | 33 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.431 | +248.03% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.54 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.65 | - | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.004 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.20 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.70 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.42 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.38 | n/a | 1 | Aug 12, 2021 |
Kazia Therapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $30
Current: $14.60
Upside: +105.48%
Quoin Pharmaceuticals
Jul 10, 2026
Reiterated: Buy
Price Target: $16
Current: $4.38
Upside: +265.71%
Vertex Pharmaceuticals
Jul 9, 2026
Reiterated: Buy
Price Target: $575
Current: $472.57
Upside: +21.68%
Scienture Holdings
Jul 9, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.40
Upside: +275.00%
Vivani Medical
Jul 8, 2026
Reiterated: Buy
Price Target: $4
Current: $1.39
Upside: +187.77%
Palisade Bio
Jun 29, 2026
Reiterated: Buy
Price Target: $8
Current: $1.90
Upside: +321.05%
Viking Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $70
Current: $37.31
Upside: +87.62%
Silexion Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $60 → $6
Current: $2.52
Upside: +138.10%
Nuvectis Pharma
Jun 23, 2026
Rated: Buy
Price Target: $17 → $30
Current: $19.29
Upside: +55.52%
Galmed Pharmaceuticals
Jun 10, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5049
Upside: -
Jun 10, 2026
Reiterated: Buy
Price Target: $12
Current: $7.90
Upside: +51.90%
Jun 3, 2026
Reiterated: Buy
Price Target: $8
Current: $4.84
Upside: +65.29%
May 22, 2026
Reiterated: Buy
Price Target: €16.00
Current: €3.79
Upside: +321.94%
May 19, 2026
Reiterated: Buy
Price Target: $2
Current: $0.411
Upside: +386.62%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $1.29
Upside: +132.56%
May 15, 2026
Rated: Buy
Price Target: $7
Current: $2.16
Upside: +224.07%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $5.82
Upside: +243.64%
May 14, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.431
Upside: +248.03%
Nov 19, 2025
Maintained: Hold
Price Target: n/a
Current: $2.54
Upside: -
Aug 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.65
Upside: -
Dec 18, 2024
Maintained: Buy
Price Target: n/a
Current: $0.004
Upside: n/a
Nov 20, 2024
Maintained: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: n/a
Current: $5.70
Upside: n/a
Jan 13, 2022
Maintained: Hold
Price Target: n/a
Current: $3.42
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $6
Current: $8.38
Upside: n/a